AzTrials
AzTrials

Very Low Birth Weight InfantNCT07229885

Comparison of Early Versus Late Trophic Feeding

A study testing Early trophic feeding and Late trophic feeding in people with Very Low Birth Weight Infant, run by RESnTEC, Institute of Research at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Local data on the neonatal outcomes in early versus late trophic feeding in preterm very low birth weight neonates in terms of mean hospital stay is scarce. Therefore, the current study was planned with the objective of comparing the neonatal outcomes in early versus late trophic feeding in preterm very low birth… Read more about this study

Who is it for?
Ages 1 day to 30 days
Conditions the study is for
Very Low Birth Weight Infant
What is being tested?
Early trophic feeding and Late trophic feeding
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePakistan
Study dates
15 May 2025to 1 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 30 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Any gender
  • Neonates aged 1-30 days
  • Preterm very low birth weight neonates

Who cannot join

  • Neonates transferred from other hospital and already started on antibiotics.
  • Neonates with congenital anomalies, hypoxic ischemic encephalopathy, central nervous system (CNS) impairment, neonatal sepsis, urinary tract infection, or one of twins or higher order multiples (on history and medical record).
  • Non-consenting parents.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Nishtar Hospital

    Multan, Punjab Province, 66000

Other trials in Pakistan

About this study

Official title: Comparison of Early Versus Late Trophic Feeding in Preterm Very Low Birth Weight Neonates at a Tertiary Care Hospital

Local data on the neonatal outcomes in early versus late trophic feeding in preterm very low birth weight neonates in terms of mean hospital stay is scarce. Therefore, the current study was planned with the objective of comparing the neonatal outcomes in early versus late trophic feeding in preterm very low birth weight neonates in terms of mean hospital stay.

Read the detailed description

Since preterm, very low birth weight births are common in society, an effective treatment modality is needed at the moment. Evaluating the length of hospital stay and occurrence of necrotizing enterocolitis in preterm very low birth weight neonates with respect to two approaches of trophic feeding in local settings will provide an insight into a better implementation of preventive strategies, resulting in reducing the hospital stays and the incidence of necrotizing enterocolitis, and hence reducing the burden on the already meager resources.

Being tested
Early trophic feeding, Late trophic feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early trophic feedingDietary supplement

    Infants will receive trophic (enteral) feeding within the first 48 hours after birth.

  • Late trophic feedingDietary supplement

    Infants will receive trophic (enteral) feeding within the first 72 hours after birth.

Study groups in NCT07229885
Study groupRoleWhat they receive
Early trophic feeding groupExperimentalInfants will receive trophic (enteral) feeding within the first 48 hours after birth.
Receives: Dietary Supplement: Early trophic feeding
Late trophic feeding groupExperimentalInfants will receive trophic (enteral) feeding after 72 hours after birth.
Receives: Dietary Supplement: Late trophic feeding

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of necrotizing enterocolitis

    Confirmation of the occurrence of necrotizing enterocolitis based on modified Bell's diagnostic criteria

    Measured: Up to 30 days

Secondary outcomes (1)
  1. Hospital stay

    Total days from admission till final outcome (discharge/death due to any case).

    Measured: through study completion, an average of 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Nov 2025
  2. Study start15 May 2025
  3. Primary completion1 Oct 2025
  4. Study completion1 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07229885
Sponsor's protocol ID
Dr-Nadeem-Nishter
Status last verified
Nov 2025
First submitted
30 Sep 2025
Last updated
17 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Data can be shared on a reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Early trophic feeding and Late trophic feeding in people with Very Low Birth Weight Infant, run by RESnTEC, Institute of Research at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of necrotizing enterocolitis (time frame: Up to 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in